162 related articles for article (PubMed ID: 3826754)
1. The pharmacokinetic and pharmacodynamic effects of varying the free fraction of disopyramide.
Shaw LM; Doherty JU; Waxman HL; Josephson ME
Angiology; 1987 Feb; 38(2 Pt 2):192-7. PubMed ID: 3826754
[TBL] [Abstract][Full Text] [Related]
2. Effect of intra-individual change in serum protein binding on the pharmacologic response of R- and S-disopyramide in the rabbit.
Huang JD; Oie S
Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):243-53. PubMed ID: 6635319
[TBL] [Abstract][Full Text] [Related]
3. Effect of altered disopyramide binding on its pharmacologic response in rabbits.
Huang JD; Oie S
J Pharmacol Exp Ther; 1982 Nov; 223(2):469-71. PubMed ID: 7131300
[TBL] [Abstract][Full Text] [Related]
4. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.
Lima JJ; Boudoulas H; Blanford M
J Pharmacol Exp Ther; 1981 Dec; 219(3):741-7. PubMed ID: 7299695
[TBL] [Abstract][Full Text] [Related]
5. Disopyramide: clinical indications, pharmacokinetics and laboratory assessment.
Taylor EH; Pappas AA
Ann Clin Lab Sci; 1986; 16(4):289-95. PubMed ID: 2427003
[TBL] [Abstract][Full Text] [Related]
6. Protein binding of disopyramide--displacement by mono-N-dealkyldisopyramide and variation with source of alpha-1-acid glycoprotein.
Haughey DB; Steinberg I; Lee MH
J Pharm Pharmacol; 1985 Apr; 37(4):285-8. PubMed ID: 2860235
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective disposition and metabolism of disopyramide in pediatric patients.
Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T
J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the binding of disopyramide to serum proteins.
Shaw LM; Altman R; Thompson BC; Fields L
Clin Chem; 1985 Apr; 31(4):616-9. PubMed ID: 3884182
[TBL] [Abstract][Full Text] [Related]
9. Plasma binding of disopyramide and mono-N-dealkyldisopyramide.
Bredesen JE; Pike E; Lunde PK
Br J Clin Pharmacol; 1982 Nov; 14(5):673-6. PubMed ID: 7138747
[TBL] [Abstract][Full Text] [Related]
10. Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay.
Raghow G; Meyer MC; Straughn AB
Ther Drug Monit; 1985; 7(4):466-71. PubMed ID: 3909539
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.
Aso R; Ohashi K; Katoh T; Ogata H
Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143
[TBL] [Abstract][Full Text] [Related]
12. Disopyramide concentrations in saliva.
Aitio ML; Virtanen R; Lammintausta R
Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):68-72. PubMed ID: 7061181
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations and protein binding of disopyramide and mono-N-dealkyldisopyramide during chronic oral disopyramide therapy.
Aitio ML
Br J Clin Pharmacol; 1981 Apr; 11(4):369-75. PubMed ID: 7259930
[TBL] [Abstract][Full Text] [Related]
14. Intravenous disopyramide in acute myocardial infarction: a haemodynamic and pharmacokinetic study.
Cameron J; Stafford W; Pritchard D; Norris R; Ravenscroft P
J Cardiovasc Pharmacol; 1984; 6(1):126-31. PubMed ID: 6199595
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients.
Masuhara K; Ohno T; Hamaguchi K; Katoh K; Kashiwada K; Takahashi S; Tanaka Y; Someya K; Ogata H
Int J Clin Pharmacol Res; 1995; 15(3):103-13. PubMed ID: 8847151
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of disopyramide and mono-N-dealkyldisopyramide enantiomers in human plasma by capillary electrophoresis.
Jabor VA; Lanchote VL; Bonato PL
Electrophoresis; 2001 Apr; 22(7):1406-12. PubMed ID: 11379964
[TBL] [Abstract][Full Text] [Related]
17. Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramide.
Giacomini KM; Blaschke TF
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():42-8. PubMed ID: 6705426
[TBL] [Abstract][Full Text] [Related]
18. Binding interaction between enantiomers of disopyramide and mono-N-dealkyldisopyramide on plasma protein.
Takahashi H; Ogata H; Seki Y
Drug Metab Dispos; 1991; 19(2):554-7. PubMed ID: 1676669
[No Abstract] [Full Text] [Related]
19. Immediate- versus controlled-release disopyramide: importance of saturable binding.
Davies RF; Siddoway LA; Shaw L; Barbey JT; Roden DM; Woosley RL
Clin Pharmacol Ther; 1993 Jul; 54(1):16-22. PubMed ID: 8330460
[TBL] [Abstract][Full Text] [Related]
20. Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.
Bredesen JE; Kierulf P
Br J Clin Pharmacol; 1984 Nov; 18(5):779-84. PubMed ID: 6508986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]